Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Mission: To dramatically improve the dialysis care experience – for patients, families, providers and physicians alike while also providing cost-efficiencies for providers.
201 to 500
TypeCompany - Public (OM)
Revenue$10 to $25 million (USD)
IndustryHealth Care Services & Hospitals
CompetitorsNxStage, Baxter, Intuitive (Intuitive Surgical)
Founded2012